BGC [BGC] vs Morgan Stanley [MS] Detailed Stock Comparison
BGC
NASDAQ
Loading...
Morgan Stanley
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: BGC wins in 6 metrics, Morgan Stanley wins in 12 metrics, with 0 ties. Morgan Stanley appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BGC | Morgan Stanley | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.80 | 16.76 | Morgan Stanley |
| Price-to-Book Ratio | 5.18 | 2.40 | Morgan Stanley |
| Debt-to-Equity Ratio | 188.35 | 438.54 | BGC |
| PEG Ratio | 0.90 | 1.03 | BGC |
| EV/EBITDA | 19.86 | N/A | N/A |
| Profit Margin (TTM) | 6.17% | 22.49% | Morgan Stanley |
| Operating Margin (TTM) | 10.76% | 34.12% | Morgan Stanley |
| EBITDA Margin (TTM) | 10.76% | 34.12% | Morgan Stanley |
| Return on Equity | 13.64% | 14.13% | Morgan Stanley |
| Return on Assets (TTM) | 3.21% | 1.16% | BGC |
| Free Cash Flow (TTM) | $243.30M | $-2.10B | BGC |
| Dividend Yield | 1.05% | 2.15% | Morgan Stanley |
| 1-Year Return | 4.54% | 45.27% | Morgan Stanley |
| Price-to-Sales Ratio (TTM) | 1.94 | 3.60 | BGC |
| Enterprise Value | $6.09B | $156.96B | Morgan Stanley |
| EV/Revenue Ratio | 2.46 | 2.39 | Morgan Stanley |
| Gross Profit Margin (TTM) | 42.30% | N/A | N/A |
| Revenue per Share (TTM) | $5 | $41 | Morgan Stanley |
| Earnings per Share (Diluted) | $0.30 | $8.83 | Morgan Stanley |
| Beta (Stock Volatility) | 1.13 | 1.32 | BGC |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
BGC vs Morgan Stanley Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BGC | 2.84% | -1.27% | 2.63% | 6.85% | 13.93% | 8.68% |
| Morgan Stanley | 2.76% | 2.34% | 5.70% | 17.23% | 13.89% | 18.62% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BGC | 4.54% | 146.72% | 288.51% | 80.43% | 188.89% | 102.80% |
| Morgan Stanley | 45.27% | 70.51% | 179.86% | 334.71% | 491.37% | 187.08% |
Performance & Financial Health Analysis: BGC vs Morgan Stanley
| Metric | BGC | MS |
|---|---|---|
| Market Information | ||
| Market Cap | $4.81B | $236.29B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 2,595,790 | 4,830,732 |
| 90 Day Avg. Volume | 2,752,803 | 5,230,214 |
| Last Close | $10.14 | $148.02 |
| 52 Week Range | $7.24 - $11.79 | $94.09 - $149.08 |
| % from 52W High | -13.99% | -0.71% |
| All-Time High | $57.80 (Mar 13, 2000) | $148.90 (Aug 22, 2025) |
| % from All-Time High | -82.46% | -0.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.42% | 0.11% |
| Quarterly Earnings Growth | 0.52% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.22% |
| Operating Margin (TTM) | 0.11% | 0.34% |
| Return on Equity (TTM) | 0.14% | 0.14% |
| Debt to Equity (MRQ) | 188.35 | 438.54 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.96 | $61.59 |
| Cash per Share (MRQ) | $2.07 | $352.68 |
| Operating Cash Flow (TTM) | $412.29M | $-17,670,000,640 |
| Levered Free Cash Flow (TTM) | $1.48B | $12.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.05% | 2.15% |
| Last 12-Month Dividend | $0.10 | $2.79 |
Valuation & Enterprise Metrics Analysis: BGC vs Morgan Stanley
| Metric | BGC | MS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.80 | 16.76 |
| Forward P/E | 9.57 | 18.67 |
| PEG Ratio | 0.90 | 1.03 |
| Price to Sales (TTM) | 1.94 | 3.60 |
| Price to Book (MRQ) | 5.18 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $4.81B | $236.29B |
| Enterprise Value | $6.09B | $156.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.46 | 2.39 |
| Enterprise to EBITDA | 19.86 | N/A |
| Risk & Other Metrics | ||
| Beta | 1.13 | 1.32 |
| Book Value per Share (MRQ) | $1.96 | $61.59 |
Financial Statements Comparison: BGC vs Morgan Stanley
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BGC | MS |
|---|---|---|
| Revenue/Sales | $652.61M | $16.52B |
| Cost of Goods Sold | $367.49M | N/A |
| Gross Profit | $285.12M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $101.49M | N/A |
| EBITDA | $126.50M | N/A |
| Pre-Tax Income | $79.98M | $5.54B |
| Income Tax | $26.55M | $1.17B |
| Net Income (Profit) | $53.43M | $4.37B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BGC | MS |
|---|---|---|
| Cash & Equivalents | $966.36M | $60.84B |
| Total Current Assets | $3.08B | N/A |
| Total Current Liabilities | $2.41B | N/A |
| Long-Term Debt | $1.14B | $303.93B |
| Total Shareholders Equity | $1.14B | $107.85B |
| Retained Earnings | $-981.05M | $107.65B |
| Property, Plant & Equipment | $0 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BGC | MS |
|---|---|---|
| Operating Cash Flow | $-868.84M | $-67.29B |
| Capital Expenditures | $-5.25M | $-713.00M |
| Free Cash Flow | $-14.66M | $-24.69B |
| Debt Repayment | $0 | $-20.85B |
| Common Stock Repurchase | $-73.62M | $-2.03B |
Short Interest & Institutional Ownership Analysis
| Metric | BGC | MS |
|---|---|---|
| Shares Short | 12.41M | 14.60M |
| Short Ratio | 4.56 | 2.55 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 2,595,790 | 4,830,732 |
| Average Daily Volume (90 Day) | 2,752,803 | 5,230,214 |
| Shares Outstanding | 483.75M | 1.61B |
| Float Shares | 360.82M | 1.21B |
| % Held by Insiders | 0.01% | 0.24% |
| % Held by Institutions | 0.84% | 0.63% |
Dividend Analysis & Yield Comparison: BGC vs Morgan Stanley
| Metric | BGC | MS |
|---|---|---|
| Last 12-Month Dividend | $0.10 | $2.79 |
| Last 12-Month Dividend Yield | 1.05% | 2.15% |
| 3-Year Avg Annual Dividend | $0.06 | $3.10 |
| 3-Year Avg Dividend Yield | 0.21% | 0.90% |
| 3-Year Total Dividends | $0.19 | $9.31 |
| Ex-Dividend Date | Aug 20, 2025 | Jan 31, 2025 |